Vertex Pharmaceuticals Revenue, Growth & Competitor Profile

DBA VERTEX PHARMACEUTICALS INC / MA

Company Profile & Annual Report for Vertex Pharmaceuticals

Access the complete profile.

Vertex Pharmaceuticals Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	50 Northern Ave. Boston, MA 02210

Note: Revenues for privately held companies are statistical evaluations.


Vertex Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Vertex Pharmaceuticals's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Vertex Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Vertex Pharmaceuticals Annual Revenue and Growth Rate

Vertex Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Vertex Pharmaceuticals's revenues are gauged from an analysis of company filings.

Vertex Pharmaceuticals's Income Statement (based on Industry Averages)

Vertex Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Vertex Pharmaceuticals is developing and marketing. Vertex Pharmaceuticals's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ALYFTREK Pharmaceutical preparations for the treatment of cystic fibrosis	12/19/2023
GPS AXIS YOUR PORTAL TO VERTEX TREATMENT MANAGEMENT Providing health information; providing information in the fields of health and wellness; providing medical information	08/24/2023
GPS AXIS Providing health information; providing information in the fields of health and wellness; providing medical information	08/24/2023

See all trademarks and details in the Full Report.

Market Share of Vertex Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Vertex Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Vertex Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
VERTEX PHARMACEUTICALS	Boston, MA	100
ALEXION PHARMACEUTICALS	Boston, MA	57
MOTIONAL AD	Boston, MA	31
VERVE THERAPEUTICS	Boston, MA	11
PATHAI	Boston, MA	7
ODYSSEY THERAPEUTICS	Boston, MA	5

Future Competition: Vertex Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Vertex Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)